SLC44A4 and cancer: Cytotoxic T lymphocyte antigen 4 (CTL-4) and programmed cell death protein 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) are representative ICI s and antibodies against them have been widely approved by the FDA for cancer treatment (34).